Peláez Sarah S, Mahler Hanns-Christian, Herdlitschka Christoph, Wertli Toni, Kahl Matthias, Koulov Atanas, Matter Anja, Singh Satish K, Widmer Martina, Germershaus Oliver, Mathaes Roman
Lonza Drug Product Services, Basel, Switzerland.
Wilco AG, Wohlen, Switzerland; and.
PDA J Pharm Sci Technol. 2019 May-Jun;73(3):220-234. doi: 10.5731/pdajpst.2018.009332. Epub 2019 Jan 16.
The sterility of drug products intended for parenteral administration is a critical quality attribute (CQA) because it serves to ensure patient safety and is thus a key requirement by health authorities. While sterility testing is a probabilistic test, the assurance of sterility is a holistic concept including adequate design of manufacturing facilities, process performance, and product design. Container closure integrity testing (CCIT) is necessary to confirm the integrity of a container closure system (CCS), until the end of a product's shelf life. The new and revised United States Pharmacopeia (USP) General Chapter <1207> is a comprehensive guidance on CCI. Nevertheless, practical considerations including the choice of CCIT methods, the acceptance criteria, or the positive control samples (artificial leaks) must be addressed by the pharmaceutical manufacturer.This study is the first to provide a systematic comparison of four commonly used physical CCIT (pCCIT) methods [Helium (He) leak, vacuum decay, laser-based headspace analysis (HSA), and dye ingress] and four commonly used modes of creating artificial leaks (laser-drilled micro holes, copper wire introduced leaks, and two types of capillary leaks).The results from these experiments provide comprehensive data to allow a direct comparison of the capabilities of the individual methods. The results confirmed that the He leak detection method, which is considered the "gold-standard" for pCCIT regarding method sensitivity, indeed demonstrates the highest detection sensitivity (lowest detection limit). In comparison to the dye ingress method, HSA and vacuum decay also demonstrated better detection sensitivity in our study.Capillary leaks with orifice diameter (capillary leak with flow according to an ideal orifice) and micro holes yielded similar leak rates, whereas capillaries with nominal diameters yielded significantly lower leak rates. In conclusion, method sensitivity cannot be compared by means of a leak diameter, but requires the consideration of multiple impacting factors (e.g., path length, uniformity). Sterility of drug products intended for parenteral administration is a critical quality attribute to ensure patient's safety and is thus a key requirement by health authorities. The absence of microbial contamination must be demonstrated by container closure integrity (CCI) of the container closure system (CCS). Currently, the revised United States Pharmacopeia (USP) General Chapter <1207> provides the most extensive guidance on how CCI should be assessed. Nevertheless, practical considerations on the choice of an appropriate CCIT method, artificial leaks or the choice of an acceptance criteria are lacking and must be addressed by the pharmaceutical manufacturer.This study provides a systematic comparison of four commonly used physical CCIT (pCCIT) methods [Helium (He) leak, vacuum decay, laser-based headspace analysis (HSA) and dye ingress] and four commonly used modes of creating artificial leaks (laser-drilled micro holes, copper wire introduced leaks, and two types of capillary leaks).
用于肠胃外给药的药品无菌性是一项关键质量属性(CQA),因为它有助于确保患者安全,因此是卫生当局的一项关键要求。虽然无菌测试是一种概率性测试,但无菌保证是一个整体概念,包括生产设施的适当设计、工艺性能和产品设计。容器密封完整性测试(CCIT)对于确认容器密封系统(CCS)直至产品保质期结束时的完整性是必要的。新的和修订后的美国药典(USP)通则<1207>是关于容器密封完整性的全面指南。然而,制药商必须解决一些实际问题,包括CCIT方法的选择、验收标准或阳性对照样品(人工泄漏)。本研究首次对四种常用的物理CCIT(pCCIT)方法[氦(He)泄漏、真空衰减、基于激光的顶空分析(HSA)和染料渗入]以及四种常用的制造人工泄漏的方式(激光钻孔微孔、引入铜线的泄漏以及两种类型的毛细管泄漏)进行了系统比较。这些实验的结果提供了全面的数据,以便直接比较各个方法的能力。结果证实,He泄漏检测方法在方法灵敏度方面被认为是pCCIT的“金标准”,确实表现出最高的检测灵敏度(最低检测限)。在我们的研究中,与染料渗入方法相比,HSA和真空衰减也表现出更好的检测灵敏度。孔径(根据理想孔口有流量的毛细管泄漏)的毛细管泄漏和微孔产生了相似的泄漏率,而标称直径的毛细管产生的泄漏率明显较低。总之,不能通过泄漏直径来比较方法灵敏度,而是需要考虑多个影响因素(例如,路径长度、均匀性)。用于肠胃外给药的药品无菌性是确保患者安全的关键质量属性,因此是卫生当局的一项关键要求。必须通过容器密封系统(CCS)的容器密封完整性(CCI)来证明不存在微生物污染。目前,修订后的美国药典(USP)通则<1207>提供了关于应如何评估CCI的最广泛指南。然而,在选择合适的CCIT方法、人工泄漏或验收标准的选择方面缺乏实际考虑,制药商必须解决这些问题。本研究对四种常用的物理CCIT(pCCIT)方法[氦(He)泄漏、真空衰减、基于激光的顶空分析(HSA)和染料渗入]以及四种常用的制造人工泄漏的方式(激光钻孔微孔、引入铜线的泄漏以及两种类型的毛细管泄漏)进行了系统比较。